Your browser doesn't support javascript.
loading
Mutational analysis of SARS-CoV-2 variants of concern reveals key tradeoffs between receptor affinity and antibody escape.
Makowski, Emily K; Schardt, John S; Smith, Matthew D; Tessier, Peter M.
Afiliação
  • Makowski EK; Pharmaceutical Sciences, University of Michigan, Ann Arbor, Michigan, United States of America.
  • Schardt JS; Biointerfaces Institute, University of Michigan, Ann Arbor, Michigan, United States of America.
  • Smith MD; Pharmaceutical Sciences, University of Michigan, Ann Arbor, Michigan, United States of America.
  • Tessier PM; Biointerfaces Institute, University of Michigan, Ann Arbor, Michigan, United States of America.
PLoS Comput Biol ; 18(5): e1010160, 2022 05.
Article em En | MEDLINE | ID: mdl-35639784
SARS-CoV-2 variants with enhanced transmissibility represent a serious threat to global health. Here we report machine learning models that can predict the impact of receptor-binding domain (RBD) mutations on receptor (ACE2) affinity, which is linked to infectivity, and escape from human serum antibodies, which is linked to viral neutralization. Importantly, the models predict many of the known impacts of RBD mutations in current and former Variants of Concern on receptor affinity and antibody escape as well as novel sets of mutations that strongly modulate both properties. Moreover, these models reveal key opposing impacts of RBD mutations on transmissibility, as many sets of RBD mutations predicted to increase antibody escape are also predicted to reduce receptor affinity and vice versa. These models, when used in concert, capture the complex impacts of SARS-CoV-2 mutations on properties linked to transmissibility and are expected to improve the development of next-generation vaccines and biotherapeutics.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Evasão da Resposta Imune / SARS-CoV-2 / COVID-19 Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Evasão da Resposta Imune / SARS-CoV-2 / COVID-19 Idioma: En Ano de publicação: 2022 Tipo de documento: Article